NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Woodworth Marshall H
NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Tursi James Patrick
NeuroBo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Tursi James Patrick
NeuroBo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Woodworth Marshall H
NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kim Hyung Heon
NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director KOVEN ANDREW I
NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Salsbury Michael
NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director STRICKLAND D GORDON
NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GROVES JASON L
NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Glickman Mark A
NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kim Na Yeon
NeuroBo Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Kim Na Yeon
NeuroBo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Glickman Mark A
NeuroBo Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Strategic Risk, LLC.(6.3%)
NeuroBo Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Altium Growth Fund, LP(0%),Altium Capital Management, LP(0%), etc.
NeuroBo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Hooker Joseph
NeuroBo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dong-A ST Co., Ltd.(65.5%)
NeuroBo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner GOLDMAN SACHS GROUP INC
NeuroBo Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(7.7%),Altium Growth Fund, LP EIN:(7.7%), etc.
NeuroBo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dong-A ST Co., Ltd.(2.4%)
No Data